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Collaborating to offer HPV vaccinations in
jails: results from a pre-implementation
study in four states
Amanda Emerson1* , Molly Allison2, Lisa Saldana3, Patricia J. Kelly4 and Megha Ramaswamy5
Abstract
Background: Correctional facilities are an underutilized venue for reaching young adults who have not vaccinated
for human papillomavirus (HPV). The objective of this study was to identify factors that are associated with jail and
local health department (LHD) interest in partnering to offer HPV vaccinations to young adults in jail.
Methods: Consolidated framework for implementation research (CFIR)-guided surveys were conducted with jail
administrators in Iowa, Kansas, Missouri, and Nebraska, September 2017–October 2018. Jail survey data were
analyzed using chi square distribution and relative risk regression. Using data from sister surveys conducted with
LHD administrators in the same counties (results previously reported), we identified characteristics of counties in
which both the jail and LHD indicated interest in collaborating to offer HPV vaccinations in the jail.
Results: Jail survey response was 192/347 (55.3%). Surveys with LHDs yielded 237/344 (68.9%) responses. Eleven
communities were identified where both the jail and LHD expressed interest. Only “any vaccines provided in jail”
predicted shared interest (RR: 5.36; CI: 2.52–11.40; p < .01). For jail administrators, offering other vaccines was 3 times
(CI:1.49–6.01; p < .01) and employing a nurse 1.65 times more likely (CI: 1.20–2.28; p < .01) to predict interest in
collaborating to offer HPV vaccination. Open-ended responses indicated that managing linkages and stakeholder
investment were areas of emphasis where collaborations to provide vaccinations in the jails had been previously
implemented.
Conclusions: Interest in jail-LHD partnerships to provide HPV vaccinations in jails exists in the Midwest but will
require building-out existing programs and linkages and identifying and strengthening shared values, goals, and
benefits at all levels.
Keywords: Human papillomavirus, Vaccination, Prisoner populations, Health departments, Interagency collaboration
Background
Newly diagnosed human papillomavirus-associated can-
cers in the United States number approximately 34,800
per year and cost an estimated $1.7 billion [1, 2]. The
highest rates of HPV infection occur in young adults, a
group that initiates HPV vaccination at comparatively
lower rates than other recommended groups [2, 3]. The
four-state Department of Health and Human Services
(DHHS) Region VII (Iowa, Kansas, Missouri, Nebraska)
ranks eighth of ten regions for HPV vaccination cover-
age [4]. Kansas and Missouri rank in the lowest quartile
of states based on most recent National Immunization
Survey data [4].
This study focused on the vaccination needs of young
adults, ages 19–26, who move through jails in DHHS
Region VII. Justice-involved young adults are often
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exposed to social determinant and lifestyle factors that are
linked to increased risk of developing and dying from
HPV-related cancers—e.g., racial minority status, smoking,
poverty, childhood sexual abuse, early sexual debut, and
multiple sex partners [5–7]. We have known for some
time that women incarcerated in jail are 4–5 times more
likely than community samples to have been diagnosed
with cervical cancer [8]. Persons with a history of low-
level, repeated incarcerations are more likely to be over-
looked for vaccination outreach than others, as we learned
in previous research, where only 21% of vaccine eligible
adults (n = 80) in a urban Kansas jail reported receiving
any HPV vaccine, and a little over half were unaware that
such a vaccine existed [9]. Seventy percent (n = 181) re-
ported never receiving a provider’s recommendation for
HPV vaccination [10]. Poverty, lack of health insurance,
and provider hesitancy stemming from reluctance to dis-
cuss or misconceptions about the efficacy of the vaccine
for this group make HPV vaccination among justice-
involved young adults especially challenging [5, 9, 11].
Looking for solutions: bringing vaccines to incarcerated
adults
Jails are not obvious venues for preventive health care,
yet from a public health perspective they offer a poten-
tially high impact opportunity to reach an underserved
population [12]. Compared with the general population,
incarcerated persons tend to have poorer health and less
access to health services [13, 14]. Outside large urban
systems, preventive services like vaccination are rarely
provided in jails [15]. In smaller, rural communities, the
local health department—also under county jurisdiction
in most states—is a primary source of HPV and other
vaccinations for low-income adults [16]. Bringing jails
and local health departments together to offer vaccina-
tions in jails is one way to extend access to preventive
services to a justice-involved population that may other-
wise remain overlooked and underserved. Currently, not
much is known about what it would take to facilitate
jail-LHD collaborations.
In this study, we sought to learn what elements rele-
vant to interest and readiness to collaborate across agen-
cies could be identified in jails and, further, what
distinguished counties in which both jail and LHD ad-
ministrators expressed interest in collaborating to offer
HPV vaccinations in the jail. Our results may help guide
future efforts to bring agencies together to expand HPV
protection in a high-risk population and possibly offer
other vaccinations and preventive health services as well.
Methods
Design, sample, and setting
The primary sample for this cross-sectional survey study
was jail administrators in 347 counties in Kansas,
Missouri, Iowa, and Nebraska. Surveys were also con-
ducted with LHD administrators in the same communi-
ties and those results have been published previously
[17]. Both the jail and LHD administrators were identi-
fied using internet searches, state directories, and re-
search contacts, and were recruited and surveyed via
email between November 2017 and October 2018. Jails
included state jails, county jails, municipal jails, and
municipal-county jails (i.e., unified city and county). The
eligibility criterion was geographic location in a Region
VII state. Of the 412 counties in Iowa, Kansas, Missouri,
and Nebraska, 62 were excluded because they contracted
for jail services with other counties; three were excluded
because they had no geographically-associated local
health department. The LHD surveys were conducted
separately in the same Region VII counties, following
the same procedures [17] Since the LHD results have
been previously published, only the data collection and
results for the jail administrator surveys and the analysis
for the combined regression are reported below. The In-
stitutional Review Board at the University of Kansas
Medical Center approved the study protocol.
Data collection
Surveys were sent to jail administrators, beginning in
November 2017. The emails were addressed to persons
identified in directories or facility web sites as sheriff, or
a comparable administrative leadership role. After 1
week, a member of our study staff attempted to make
phone contact with administrators who did not return a
survey and offered to conduct the survey by telephone,
fax, or, where feasible, in person. We made three at-
tempts to reach administrators. The open-ended ques-
tions asked about already implemented or planned
programs. The open-ended questions were posed only to
those who answered positively to the survey question
about having already implemented vaccination in the jail
through a collaboration. These were invited via email
and the questions were administered via phone by a
trained Master of Public Health student who took notes
and read back responses to verify accuracy.
Measures
The jail administrator survey, like the nearly identical
health department survey, was created by the authors for
this study and was based on CFIR domains [18] and the
results of a previously published focus group study that
we conducted with six jail administrators and seven
LHD administrators [19]. The survey development is
discussed in a supplemental file published with the art-
icle in which we reported on results from the LHD sur-
veys [17]. Copies of the surveys themselves (jail and
LHD) are available as Additional files 1 and 2 in the on-
line version of this article. The jail survey elicited
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information about our primary dependent variable,
interest in collaborating with the LHD to offer HPV vac-
cinations to adults during a jail detention. This question
read: “How ready is your facility for implementing an
HPV vaccination program with the help of a local health
department?” Respondents could choose from among
three positive responses (“Already implemented,” “Inter-
ested and has some groundwork laid to implement,” and
“Interested in learning more about implementation”)
and two negative responses (“No interest or intention to
implement,” “Don’t know/Declined”). The question cor-
responded with CFIR domains 3 (inner setting—readi-
ness for implementation) and 4 (characteristics of
individuals—individual stage of change) [18].
Other questions addressed facility size and number of
staff, jail admissions per year, health care services avail-
able, and types of providers staffed. The survey assessed
perceptions about priority and perceived suitability of of-
fering vaccinations; priority health care needs of the
detained adult population; and potential challenges and
opportunities for collaborating to offer HPV vaccine, in-
cluding security concerns, cost, and logistics related to
communication, space, and documentation/recordkeep-
ing. The 12 open-ended questions about initiation, de-
velopment, facilitators, and impediments of already
implemented programs appear in Additional file 3.
Data analysis
Jail administrator survey
We calculated frequencies for categorical variables and
means, medians, and standard deviations (SD) for con-
tinuous variables and used chi-square tests for goodness
of fit to evaluate differences in proportions. Characteris-
tics of the jails and interest in an HPV vaccination pro-
gram were analyzed first by state to determine whether
state-level variations existed that might affect future
intervention design and implementation. We used modi-
fied Poisson relative risk regression to evaluate associa-
tions between the dependent variable (jail interest) and
characteristics of the jails. The dependent variable of
interest was dichotomized as positive: 0 = already imple-
mented; interested/has groundwork; and interested in
learning more; or negative: 1 = no interest or don’t know.
Median cut points were used to dichotomize continuous
measures. Counties were coded either as metropolitan
or nonmetropolitan based on designations of the Na-
tional Center for Health Statistics which categorizes stat-
istical areas based on population center sizes, population
density, and community characteristics [20]. Variables
not meeting the confidence threshold (p ≥ 0.05) were
eliminated stepwise from the model until an optimal set
was estimated. All analyses were conducted in SAS ver-
sion 9.4.
Shared jail-LHD interest in collaborating to offer HPV
vaccinations
Using matched data from our previously reported health
department administrator surveys (n = 237) [17] and the
jail survey data from this study, we also compared coun-
ties where the jail and LHD both expressed interest with
counties where there was no shared interest in order to
identify which variables were associated with having
shared interest. After removing variables of least signifi-
cance and those for which there was no correspondence
(i.e., questions in one survey with no matches in the
other), we applied modified Poisson relative risk regres-
sion to estimate a best-fit model for counties with the
shared interest.
Open-ended questions
The first author coded CFIR domains and constructs
[18] in the open-ended responses and used content ana-
lysis techniques to reduce the patterns to themes [21].
The themes and their application were reviewed by all
authors, with consensus about themes achieved through
discussion. Themes were brought together with the sur-
vey results to help reflect on how barriers and facilitators
identified in the surveys might play out in actual
implementation.
Results
Characteristics of responding jails
We received surveys from 192/347 (55%) jails in Iowa
(n = 26), Kansas (n = 70), Missouri (n = 58), and Neb-
raska (n = 38). T-tests did not show significant differ-
ences between responding and non-responding jails by
state. The majority of jails were county-administered
(n = 165; 85.9%) or combined county-municipal entities
(n = 26; 13.5%). One state facility responded. Responding
counties were mostly nonmetropolitan or rural (n = 138;
74.5%), and 99 of the nonmetropolitan were also non-
core (i.e., having no anchor community with a popula-
tion density > 10,000 persons). These results are in
keeping with the rural profile of the majority of counties
in the Region VII states.
Our primary outcome variable was captured in a ques-
tion that tapped constructs of readiness for implementa-
tion from the CFIR domains 3 (inner setting) and 4
(characteristics of individuals) by querying administra-
tors’ interest in collaborating to provide HPV vaccine
(see survey; Additional file 1). The 45 positive responses
(dichotomized as “yes”) included “Already have a pro-
gram” (n = 1); “Interested and have some groundwork
laid to implement” (n = 1); and “Interested in learning
more about implementation” (n = 43). Negative re-
sponses (dichotomized as “no”) included “No interest or
intention to implement” (n = 90) and “Don’t know/De-
clined” (n = 54). Thirty-six jails indicated that they had
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ever offered any vaccinations to persons incarcerated in
jail, but only four indicated HPV vaccine.
Jail interest in offering HPV vaccination
Chi-square, bivariate analysis detected significant
(p < .05) relationships between jail administrators’ inter-
est in offering HPV vaccine and six independent vari-
ables: (a) having a registered nurse on staff at the jail, (b)
providing any vaccines in the jail, (c) concerns regarding
cost, (d) having a medical clinic in the jail where vac-
cines could be administered, (e) not answering “Don’t
know” to the question about whether there was space in
the jail where vaccine could be administered, and (f) of-
fering treatment for sexually transmitted infections
(STIs) in the jail.
Poisson relative risk regression, which included data
only for respondents who provided an answer to the
readiness/interest question (n = 141), yielded a model
with two factors remaining significant: any vaccines
already provided to inmates (CI: 1.49–6.01; p < .01) and
having a registered nurse on staff (CI: 1.20–2.28; p < .01)
(Table 1). Jails in communities with a history of offering
vaccines to detainees were 3 times more likely to be in-
terested in partnering with health departments to offer
HPV vaccine than jails that had no previous or existing
program. Jails with a registered nurse (RN) on staff were
1.65 times more likely to affirm interest in collaboration
than jails with no RN on staff.
Shared jail-LHD interest in offering HPV vaccination
Eleven counties in the four-state region demonstrated
shared jail-LHD interest in offering vaccinations in the
jails: Missouri (5), Kansas (3), Nebraska (2), and Iowa
(1). Shared interest was found most frequently in coun-
ties that were nonmetropolitan (n = 9) but also included
two large fringe metropolitan counties—Douglas
County, Nebraska, and St. Louis County, Missouri. Nei-
ther state nor metropolitan/nonmetropolitan designation
was a significant variable for shared interest.
The sole factor in the model predictive of shared inter-
est was vaccines already provided in the jail (RR = 5.36,
CI: 2.66–11.94, p < .01) (Table 2).
Open-ended responses
Of 36 administrators who responded that they had
already implemented or had groundwork to implement
vaccinations through a collaboration, five administrators
in five different counties provided further information
through open-ended follow-up questions. Respondents
were health department administrators in Kansas (1)
and Missouri (3) and one jail administrator in Missouri.
Two were from counties where the jail and LHD collab-
orated to offer HPV vaccinations in the jail. The other
three were from counties where collaborations had been
formed to offer influenza, tetanus, hepatitis A, or hepa-
titis B vaccinations.
Two patterns identified in the open-ended responses
were managing linkages and stakeholder investment.
Managing linkages reflected CFIR outer and inner set-
ting domains and was exemplified in responses that de-
scribed established lines of interagency communication,
resource-sharing, reciprocal programming, and physical
contiguity or proximity of the participating entities.
These emphases helped unpack the survey finding that
the greatest predictor of shared interest was existence of
a previous program. In one community in which an
LHD already provided HPV vaccinations in the jails, the
LHD administrator, when asked to describe the advent
of the program, sketched a complex but apparently
workable coordination of staffing and resources across
agencies. The program came about originally because
the health department had vaccine on hand that was
about to expire and, in the LHD administrator’s account,
there were no takers in the community. With the jail
physically proximate (“caddy-corner”) to the health de-
partment, the LHD administrator, who already helped
coordinate tuberculosis (TB) testing in the jail, called the
nurse who worked in the jail who then “checked with in-
mates to see if anyone wanted it.” Communications were
facilitated by proximity, precedent, and a desire to con-
serve resources by sharing them. In another community,
where the jail was “just a few blocks” away, the LHD ad-
ministrator described a “strong working relationship” in
which LHD nurses provided services in the jail, includ-
ing screening for STIs and providing hepatitis A vaccina-
tions. The open-ended responses provided detail about
how facilitators could be leveraged and barriers to col-
laboration offset by strategically managing communica-
tion, sharing resources, and enhancing perceptions of
mutual benefit, especially in situations where LHDs and
jails were physically near and relationships between ad-
ministrators and staff already established.
Stakeholder investment was the second prominent
theme in the open-ended responses. Stakeholder invest-
ment was related to CFIR domains of inner setting and
individual characteristics. We learned that, in several
Table 1 Relative risk regression for predictors of jail interest in collaborating to offer HPV vaccination
Independent Variable Risk Ratio 95% Confidence Interval p-value
Having a registered nurse on staff 1.65 1.20–2.28 < 0.01
Providing any vaccines in the jail 3.00 1.49–6.01 < 0.01
Emerson et al. BMC Health Services Research          (2021) 21:309 Page 4 of 7
communities where vaccination programs had been im-
plemented in a jail (3 of the 5), the sheriff played a cen-
tral role in launching the partnership. A sheriff in one
community initiated a collaboration following a routine
interagency needs assessment meeting with an LHD ad-
ministrator. In another community, a state-level vaccin-
ation coordinator spearheaded a jail-LHD program to
offer vaccinations in the jail. Importantly though, initial
facilitation from the top was not enough to sustain a
program when nurses, guards, and others were not ready
to lend support. One LHD administrator described en-
thusiastic endorsement by the county sheriff followed by
a frustrating and fruitless months’ long effort to get staff
members at the jail to schedule a nurse’s visit. The
closed survey results showed that a jail’s interest in part-
nering with an LHD was significantly associated with
having a nurse on staff; indeed, nearly all who provided
open-ended responses referred to the facilitating role of
either a jail or LHD nurse who coordinated and per-
formed the vaccinations. Stakeholder investment more
generally highlighted the importance of creating and
maintaining multilevel engagement—among nurses,
sheriffs, guards, county- and state-level vaccination coor-
dinators, and, though noted to a lesser extent, persons
detained in the jails.
Discussion
A focus on HPV vaccination in jails is uncommon [11,
22]—few investigations have been made into implement-
ing vaccinations in correctional facilities at all. This
could be because, as our own and other research has
shown, jail administrators tend to identify substance
abuse and mental health as the top health care priorities
in their facilities, not preventive or routine health ser-
vices [23]. Only 8% of jail administrators in this study in-
dicated that “lack of regular health care” was the top
priority health care need for persons detained in their
jails. Yet, the literature abounds with evidence that in-
carcerated persons suffer disproportionately from a
range of chronic and infectious conditions—hyperten-
sion, diabetes, asthma, TB, human immunodeficiency
virus (HIV), hepatitis C virus (HCV), HPV—requiring
preventive, routine, acute, and maintenance care [13, 14,
24].
Our primary result indicated that having any history of
offering vaccinations in the jails predicted a community’s
having a shared (jail-LHD) interest in collaborating to
offer HPV vaccine in the jails. The open-ended re-
sponses gave some insight into why this variable, corre-
sponding to CFIR inner-setting construct readiness for
implementation, might be so important. Respondents
described how barriers to collaboration were fewer when
systems were in place to manage linkages by facilitating
communication, (re) allocating resources, and promoting
staff perceptions of mutual goals and benefits. Other re-
searchers have reported similar findings about the role
of pre-existing interagency connections. A group at the
University of Nebraska Medical Center in Omaha, Neb-
raska, credited an established 6 years’ partnership be-
tween the university medical center, Omaha public
health department, and the Omaha jail with facilitating
implementation of their STI education and testing pro-
gram for persons entering and leaving jail [25]. Similarly,
Corcoros, Nettle, and Church cited a 15-year HIV-
testing partnership between the Barnstable County, Mas-
sachusetts, jails and LHD as contributing to the success
of their collaborative HCV screening study in the Cape
Cod jails [26]. Lee et al. found that having pre-
established interagency linkages between jails and health
departments facilitated communication and contributed
significantly to the availability of influenza vaccine in
smaller jails [27]. Lobato, Roberts, Bazerman, and Ham-
mett’s national survey of jail-LHD collaborations in TB
control (e.g., screening at admission, referrals at dis-
charge) in large jails showed that the greater the number
of pre-existing points of collaboration between jails and
health departments the more positive either agency’s
perceptions of their interagency TB control collabora-
tions [28].
We found from the surveys that having nurses on staff
in a jail was significantly related to jail administrators’
receptivity to collaboration, which corresponded with re-
sponses in the open-ended questions that pointed to the
importance of obtaining buy-in at multiple
organizational levels. Costumbrado, Stirland, and Cox’s
intervention pilot of a collaborative program between
the LHD and jail to provide HCV testing in the Los
Angeles county jail yielded similar findings [29]. Essen-
tial to that implementation was comprehensive (top-to-
bottom) stakeholder engagement, including “custody
personnel (i.e., Sheriff’s deputies, custody assistants, vol-
unteers, and support staff), public health program
Table 2 Relative risk regression for predictors of shared (jail-LHD) interest in collaborating to offer HPV vaccination
Independent Variablea Risk Ratio 95% Confidence Interval P-value
Urbanization (metropolitan county) 0.45 0.19–1.30 0.16
Any vaccines provided to inmates 5.36 2.52–11.40 < 0.01
STI treatment offered 1.73 0.78–3.82 0.18
aVariables of least significance removed
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partners, and medical staff” [29] (p. 6881). The import-
ance of nurses as stakeholders may also reflect the likeli-
hood that administrators in jails with registered nurses
on staff would be more apt to recognize vaccinations as
lying within their purview than those without nurses.
Data in this study were self-reported, thus susceptible
to selection bias toward an interest in health services
programming for persons during incarceration. Our
merging of jail and LHD survey data to estimate a model
for positive, shared interest in a collaboration was lim-
ited by differences in items on the two surveys, so that
some points of comparison were either inexact or were
unique to one or the other and had to be omitted from
the matched analysis. While we had adequate power to
detect effects in the jail surveys, the very small sample in
the shared interest analysis (n = 11) could have con-
strained our ability to detect relationships. The open-
ended responses were helpful to us in conceptualizing
how the quantitative findings might play out in the field,
but they also garnered very few responses. That there
was general consistency in results from the surveys, our
preliminary case study [19], and the related literature
strengthened our confidence in the generalizability of
results.
Conclusions
Over 10 million jail admissions are logged in the US
each year. Persons with a history of incarceration
struggle with chronically poor health and life situa-
tions that put them at high risk for STIs like the
cancer-causing HPV. Jails present a unique opportun-
ity for prevention, though one rarely taken, since
most jails provide only minimal health services. Inter-
agency collaborations offer a promising way to extend
services to groups who may otherwise be difficult to
reach, particularly in smaller, rural communities. In
the case of HPV vaccination, our pre-implementation
survey of jail and LHD administrators in counties in
four Midwestern states indicated that virtually none
offered HPV vaccinations in the jails—though about a
third indicated interest. Administrators in counties
where any vaccinations had been provided through a
jail-LHD partnership provided further insight into
how existing programs and available, qualified clini-
cians can facilitate implementation. Implementation
planning should concentrate on fostering connections
between agencies. This would require purposeful le-
veraging of historical and existing programs and de-
velopment of worker commitment at all levels.
Successful jail-LHD partnerships could increase access
to HPV vaccination for an underserved population,
potentially preventing cancers, saving lives, and con-
tributing to a more equitable culture of health.
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